Results 191 to 200 of about 14,917 (246)

Eplerenone, diabetes, and chronic kidney disease in patients hospitalized for acute heart failure: findings from the EARLIER trial. [PDF]

Cardiovasc Diabetol
Kobayashi M, Yamashina A, Satomi K, Watanabe M, Takagi R, Tezuka A, Ito S, Asakura M, Kitakaze M.   +8 more
europepmc   +1 more source

An individual treatment effect approach to predict response to mineralocorticoid receptor antagonists in patients with heart failure and reduced ejection fraction. [PDF]

Eur J Heart Fail
Kobayashi M, Duarte K, Ferreira JP, Baudry G, Monzo L, McMurray JJV, Van Veldhuisen DJ, Pitt B, Zannad F, Girerd N.   +9 more
europepmc   +1 more source

Post-infectious Myocarditis: A Rare Complication of Campylobacter Gastroenteritis. [PDF]

Cureus
Al Smadi T, Zaldua P, Hein A.
europepmc   +1 more source

Dose optimization and utilization trends of mineralocorticoid receptor antagonists in heart failure patients with reduced ejection fraction in Ethiopia. [PDF]

Am Heart J Plus
Hassen M, Worku BT, Solomon T, Demessie MB, Wendie TF, Muhammed OS, Gobezie MY.   +6 more
europepmc   +1 more source

Formulation and Characterization of Eplerenone Nanocrystal as Sublingual Fast-dissolving Film

Hawraa A. Kareem, Nawal Rajab
openalex   +2 more sources

The role of finerenone in the concomitant management of chronic kidney disease-type 2 diabetes and the implication for heart failure prevention and treatment. [PDF]

Heart Fail Rev
Taub PR, Greene SJ, Fudim M.
europepmc   +1 more source

First European case of Geller syndrome complicated with hypokalemic nephropathy: A case report and literature review. [PDF]

Metabol Open
Gavriilidis E, Antoniadou C, Dimopoulou G, Papadimitriou E, Bakola SA, Papagoras C, Skendros P, Tsilingiris D.   +7 more
europepmc   +1 more source

A 74-Year-Old Man with Massive Ascites: A Case Report of Yellow Nail Syndrome. [PDF]

Reports (MDPI)
Stamatiou I, Ntoga M, Karagiannis C, Valsamaki PN, Papazoglou D, Rafailidis P.   +5 more
europepmc   +1 more source

パーシャルアゴニスト　カッセイ　ヲ　ユウスル　シンキ　MR　キッコウヤク　ノ　ヤクリ　サヨウ　ニカンスル　ケンキュウ　コウカリウム　ケッショウ　リスク　テイゲンカ　ニ　チャクモク　シタ　シンキ　チリョウ　センリャク [PDF]

ナリアイ, テツロウ, 成相, 哲朗   +1 more
core  

To MRAs treatment or not? evidence from a meta-analysis of randomized controlled trials of different MRAs on cardiovascular health in heart failure. [PDF]

Front Cardiovasc Med
He J, Chen G, Huo Y, Zhang C, Xue H, Wang J, Zhong Y, Xiao J, Shen H, Feng J.   +9 more
europepmc   +1 more source